HAOHAI BIOTEC (06826) announced that Dr. Hou Yongtai has tendered his resignation as an executive director, chairman of the board, and member of the board's Nomination Committee and Strategy and Sustainable Development Committee, effective from May 29, 2026, when the board received his resignation letter. The resignation is due to age reasons. According to the company's articles of association, Dr. Hou will also cease to serve as the company's legal representative. Following his resignation from the aforementioned positions, Dr. Hou will continue to hold positions in several subsidiaries of the company and has been appointed as the company's Chief Scientific Advisor. Mr. Wu Jianying, an executive director and the General Manager of the company, has been elected as the chairman of the board to succeed Dr. Hou, effective from May 29, 2026, until the expiration of the term of the sixth board of directors. In accordance with the company's articles of association, the company's legal representative has also been changed from Dr. Hou to Mr. Wu Jianying. Following the election of Ms. Tian Min, Mr. Chen Shaoyu, Mr. Song Yuanyang, and Ms. Xu Duoqi as directors at the annual general meeting, and the resignations of Dr. Hou, Mr. Jiang Zhihong, Mr. Su Zhi, and Mr. Yang Yushe from their respective positions on the board and its specialized committees, Mr. Wu Jianying has been elected as a member of the company's Nomination Committee; Mr. Chen Shaoyu has been elected as a member of the board's Audit Committee and Strategy and Sustainable Development Committee; Mr. Song Yuanyang has been elected as chairman of the board's Remuneration and Appraisal Committee and a member of the Audit Committee, Nomination Committee, and Strategy and Sustainable Development Committee; and Ms. Xu Duoqi has been elected as chairman of the Nomination Committee and a member of the Audit Committee and Remuneration and Appraisal Committee.